NRNP 6557 Week 3 Case Management Paper Example

Course	NRNP 6557 Adult Acute Care: Comprehensive Patient Management II
Week	Week 3
Paper type	Case management paper
Length	About 1,190 words, 7 pages
Format	APA 7 student paper
School	Walden University
Program	MSN Adult-Gerontology Acute Care Nurse Practitioner (AGACNP)
Updated	October 2026

Free sample paper for NRNP 6557 Week 3

Case Management Paper: Ulcer Bleeding Against a Five-Week-Old Coronary Stent, and Why the Ulcer Goes First for Seventy-Two Hours

Student Name

College of Nursing, Walden University

NRNP 6557: Adult Acute Care: Comprehensive Patient Management II

Instructor Name

Month Day, Year

What this page is doingThe title states the ordering decision and its time limit. A case management paper loses most often by describing both conditions and never saying which one goes first; this title makes the claim before the first heading.

Case Management Paper: Ulcer Bleeding Against a Five-Week-Old Coronary Stent, and Why the Ulcer Goes First for Seventy-Two Hours

Presentation

The patient, a composite, is a retired commercial fisherman aged 67 with type 2 diabetes, hypertension, and chronic kidney disease stage 3a, who had a non-ST-elevation myocardial infarction five weeks ago, when his left anterior descending artery was stented. He was discharged on aspirin 81 mg daily and ticagrelor 90 mg twice daily. Over the past month he added over-the-counter naproxen for knee pain. He presented with two days of melena and a syncopal episode at home. On arrival his pulse was 112 with a systolic pressure of 96; laboratory values showed hemoglobin at 7.4 g/dL against 13.1 at discharge, urea nitrogen at 58 mg/dL, and creatinine at 1.9 mg/dL. Glasgow-Blatchford score 16, placing him at high risk of needing intervention (Blatchford et al., 2000). ECG showed sinus tachycardia without new ischemic changes; troponin was unchanged from his discharge value. Endoscopy within 24 hours showed a duodenal bulb ulcer measuring 1.5 cm; its visible vessel was not bleeding and was closed with clips after an epinephrine injection.

Problem Inventory

Active: duodenal ulcer bleeding after endoscopic therapy; recent drug-eluting stent on dual antiplatelet therapy; acute blood loss anemia; acute kidney injury on chronic kidney disease; type 2 diabetes with insulin adjusted for fasting; naproxen use, now stopped; hypertension with home drugs held. Background: knee osteoarthritis, hyperlipidemia on high-intensity statin, Helicobacter pylori status pending. The full ranked list with justifications was completed on hospital day 2; this paper concerns the collision between the first two entries.

The Collision

Stated plainly: every intervention that protects the stent threatens the ulcer, and every intervention that protects the ulcer threatens the stent. Antiplatelet therapy is the reason the ulcer bled as heavily as it did, and it will make rebleeding more likely while the clipped vessel heals. Stopping antiplatelet therapy removes that pressure but exposes a stent placed five weeks ago, before its struts are fully covered by endothelium, to thrombosis, which typically presents as an ST-elevation myocardial infarction and carries high mortality. Neither condition can simply wait for the other. The decision is not which one matters, but which one leads in which window of time, and what is done for the other while it waits.

What this page is doingThe collision gets its own short section and is stated in one sentence a grader can quote. Everything after it is organized as a response to that sentence.

The Ordering Argument

The ulcer leads for the first 72 hours after endoscopic therapy, and the stent leads after that. Three lines of evidence support that ordering.

First, rebleeding risk is concentrated early. In a randomized trial of high-dose intravenous omeprazole after endoscopic treatment of actively bleeding ulcers or nonbleeding visible vessels, most recurrent bleeding in both groups occurred during the first three days, and the infusion reduced recurrence within 30 days from 22.5% to 6.7% (Lau et al., 2000). The American College of Gastroenterology guideline recommends high-dose proton pump inhibitor therapy for 3 days after endoscopic hemostasis, followed by twice-daily oral therapy for two weeks (Laine et al., 2021). A 72-hour window is therefore not arbitrary; it is the period in which the ulcer poses the greatest threat.

Second, the stent can be protected in part during that window without the full antiplatelet load. Aspirin taken for secondary cardiovascular prevention should not be held during acute gastrointestinal bleeding, and if interrupted should be resumed on the day endoscopic hemostasis is confirmed (Abraham et al., 2022). That recommendation rests partly on a randomized trial in which continuing low-dose aspirin after endoscopic control of ulcer bleeding did not significantly increase recurrent bleeding, 10.3% versus 5.4%, while all-cause mortality at 8 weeks was lower with aspirin than with placebo, 1.3% versus 12.9% (Sung et al., 2010). Keeping aspirin while ticagrelor is paused gives the stent single antiplatelet protection through the highest-risk bleeding window.

Third, the stent's risk rises with the duration of the interruption, so the ticagrelor pause must be short and planned rather than open-ended. The European Society of Cardiology's focused update on dual antiplatelet therapy sets out an approach to bleeding in which dual therapy is resumed as soon as it is judged safe, and in which switching to a less potent P2Y12 inhibitor is considered after significant bleeding (Valgimigli et al., 2018). That supports restarting a P2Y12 inhibitor after the early rebleeding window rather than waiting for the ulcer to heal completely.

The alternative ordering, stent first with dual therapy continued throughout, was considered and rejected. It would keep the stent maximally protected, but it would do so during the 72 hours when rebleeding is most likely, in a man who has already lost nearly half his hemoglobin and fainted. A rebleed would not only threaten him directly; it would force a longer and less controlled interruption of all antiplatelet therapy, which is worse for the stent than a short planned pause.

What this page is doingThe ordering argument commits to a sequence with a time boundary and puts the evidence where the decision is contested: rebleeding timing, aspirin continuation, and restart timing. The rejected alternative is stated fairly and answered.

Plan, in That Order

1. Bleeding control, hours 0 to 72: continuous high-dose proton pump inhibitor infusion; nothing by mouth for the first 24 hours after endoscopy, then clear liquids advancing as tolerated; hemoglobin every 12 hours; stool and vital sign monitoring.

2. Stent protection during the window: aspirin 81 mg daily continued without interruption. Ticagrelor held, with a documented restart plan agreed with cardiology on day 1 rather than left open.

3. P2Y12 restart, at 72 hours if there is no rebleeding: resume a P2Y12 inhibitor, with the choice between ticagrelor and a switch to clopidogrel made with cardiology; the ESC update's option of a less potent agent after significant bleeding is the basis for considering the switch (Valgimigli et al., 2018). Oral twice-daily proton pump inhibitor for two weeks, then daily while he remains on dual therapy.

4. Anemia: transfuse to keep hemoglobin at or above 8 g/dL, rather than 7, given his recent infarction; the reasoning is argued in the week 4 discussion. The 7 g/dL threshold that improved survival in acute upper gastrointestinal bleeding came from a trial that excluded patients with acute coronary syndromes (Villanueva et al., 2013), and in patients with myocardial infarction and anemia a liberal strategy had a lower, though not statistically significant, rate of death or reinfarction (Carson et al., 2023).

5. Kidney: isotonic fluid and blood as needed, metformin and lisinopril held, creatinine daily; restart lisinopril when creatinine returns to baseline.

6. Cause: naproxen stopped permanently, with acetaminophen for knee pain and a referral to discuss joint injection; Helicobacter pylori biopsy followed up and treated if positive.

Monitoring: How the Ordering Will Be Judged

The ordering was right if, at 72 hours, there has been no rebleeding (no new melena or hematemesis, hemoglobin stable within 1 g/dL of its post-transfusion value, heart rate under 100) and no cardiac event (no chest pain, no new ST-segment changes, troponin flat). It was wrong in the bleeding direction if he rebleeds despite the ticagrelor pause, which calls for repeat endoscopy and reconsideration of aspirin. It was wrong in the stent direction if he develops chest pain or ECG changes during the pause, which calls for immediate cardiology involvement and would make antiplatelet therapy the first priority regardless of the ulcer. Each of these signs is recorded every shift for the first 72 hours, and the plan names the clinician who reviews them.

References

Abraham, N. S., Barkun, A. N., Sauer, B. G., Douketis, J., Laine, L., Noseworthy, P. A., Telford, J. J., & Leontiadis, G. I. (2022). American College of Gastroenterology-Canadian Association of Gastroenterology clinical practice guideline: Management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period. The American Journal of Gastroenterology, 117(4), 542-558. https://doi.org/10.14309/ajg.0000000000001627

Blatchford, O., Murray, W. R., & Blatchford, M. (2000). A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. The Lancet, 356(9238), 1318-1321. https://doi.org/10.1016/S0140-6736(00)02816-6

Carson, J. L., Brooks, M. M., Hébert, P. C., Goodman, S. G., Bertolet, M., Glynn, S. A., Chaitman, B. R., Simon, T., Lopes, R. D., Goldsweig, A. M., DeFilippis, A. P., Abbott, J. D., Potter, B. J., Carrier, F. M., Rao, S. V., Cooper, H. A., Ghafghazi, S., Fergusson, D. A., Kostis, W. J., . . . Alexander, J. H. (2023). Restrictive or liberal transfusion strategy in myocardial infarction and anemia. The New England Journal of Medicine, 389(26), 2446-2456. https://doi.org/10.1056/NEJMoa2307983

Laine, L., Barkun, A. N., Saltzman, J. R., Martel, M., & Leontiadis, G. I. (2021). ACG clinical guideline: Upper gastrointestinal and ulcer bleeding. The American Journal of Gastroenterology, 116(5), 899-917. https://doi.org/10.14309/ajg.0000000000001245

Lau, J. Y., Sung, J. J., Lee, K. K., Yung, M. Y., Wong, S. K., Wu, J. C., Chan, F. K., Ng, E. K., You, J. H., Lee, C. W., Chan, A. C., & Chung, S. C. (2000). Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. The New England Journal of Medicine, 343(5), 310-316. https://doi.org/10.1056/NEJM200008033430501

Sung, J. J., Lau, J. Y., Ching, J. Y., Wu, J. C., Lee, Y. T., Chiu, P. W., Leung, V. K., Wong, V. W., & Chan, F. K. (2010). Continuation of low-dose aspirin therapy in peptic ulcer bleeding: A randomized trial. Annals of Internal Medicine, 152(1), 1-9. https://doi.org/10.7326/0003-4819-152-1-201001050-00179

Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J.-P., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P., Mauri, L., Montalescot, G., Neumann, F.-J., Petricevic, M., Roffi, M., Steg, P. G., Windecker, S., Zamorano, J. L., Levine, G. N., & ESC Scientific Document Group. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. European Heart Journal, 39(3), 213-260. https://doi.org/10.1093/eurheartj/ehx419

Villanueva, C., Colomo, A., Bosch, A., Concepción, M., Hernandez-Gea, V., Aracil, C., Graupera, I., Poca, M., Alvarez-Urturi, C., Gordillo, J., Guarner-Argente, C., Santaló, M., Muñiz, E., & Guarner, C. (2013). Transfusion strategies for acute upper gastrointestinal bleeding. The New England Journal of Medicine, 368(1), 11-21. https://doi.org/10.1056/NEJMoa1211801

What the NRNP 6557 Week 3 instructions ask for

Week 3 of NRNP 6557 usually asks for a case management paper on a patient whose problems conflict. You present the case, list the problems, explain where their treatments collide, argue for an order of priority, lay out the plan in that order and describe how you will monitor whether the order was right. Faculty often grade structure as heavily as content. Cite guidelines and trials for each part in APA 7. A formal framework is optional in many sections. The conflict should be real and specific. Interprofessional input, such as cardiology, should appear where it shapes the plan. NRNP 6557 faculty want the collision named in one sentence before the plan begins. The ordering argument should cite evidence for both sides. Monitoring should name the signs that would show the order was wrong.

How the NRNP 6557 Week 3 example is put together

The paper runs the length a mid-term assignment usually wants, title page and references included, on a composite adult admitted with something acute over a chronic condition that will not sit quietly. Inside it: a presentation section of a page or less, an inventory of problems, a passage where the collision between the two conditions is stated plainly, the ordering argument, a plan written in the order that argument produced, and monitoring parameters that would tell a reader whether the ordering was right. Six to ten current sources support the argument, weighted toward the contested decision rather than spread evenly. Headings follow the classroom template where one is supplied. Nothing in the paper is drawn from a real chart or from any document a preceptor signed.

NRNP 6557 Week 3 rubric: what earns full marks

Most of the loss in Week 3 papers is structural rather than clinical. A paper can describe both conditions accurately and still land mid-range because it never states which one goes first, leaving the grader to infer an argument that was never made. The second common loss is a plan out of step with the ordering: the argument defends treating one problem first, then the plan lists interventions in textbook sequence. Third, evidence spread evenly across every claim starves the contested decision, which is the only claim that needed support. Thin monitoring costs a section's worth of points on its own. APA errors and a missing conclusion trim the rest, and a paper over the word ceiling can lose marks before the argument is even read.

NRNP 6557 Week 3 help from the desk

Case papers lose much of their credit when both conditions are described accurately but no order is argued. Make the ordering argument explicit. Another common gap is stopping antiplatelets entirely with a five-week-old stent, which risks stent thrombosis. Explain what continues and what pauses, and for how long. Writers also skip monitoring, so the reader cannot tell how the decision will be judged. Name the signs. Avoid presenting the plan by system when the argument is about sequence. Include who decides on resuming ticagrelor. Keep values consistent with earlier weeks. Close with the 72-hour checkpoint. Writers also forget to say who decides on resuming ticagrelor and when. Name cardiology and a time frame. Another frequent slip is ignoring kidney disease when choosing drugs and contrast. Mention it.

Get a NRNP 6557 Week 3 example written to your instructions

Send the Week 3 prompt, the rubric and any exemplar paper your classroom posted, and a case management paper example comes back matched to that structure and length. The first one costs nothing and lands inside 24 to 48 hours. Clinical logs, encounter forms and preceptor evaluations are yours alone and never part of what we produce.

More NRNP 6557 papers and AGACNP samples

NRNP 6557 Week 3 questions, answered

How long is the finished paper?

The sample sits in the range these assignments usually occupy, roughly five to seven pages of body text with title and reference pages on top. Walden publishes no page counts week by week, and section faculty set their own ceilings, so the number in your prompt governs. Send it along and the example is written to that length rather than to a guess.

Do the two conditions have to be related?

They do not, and the harder version of this assignment is often one where they are not. Two unrelated problems competing for the same window force a genuine ranking, while two linked problems let a writer treat one and claim the other improved. The sample uses conditions that interact enough to matter but not so much that the ordering answers itself.

Does the paper need a formal framework?

Only if the prompt names one. Where a section asks for a specific model, the example threads it through the ordering argument rather than bolting a paragraph about the model onto the front. Where no model is required, the argument carries itself on evidence and case detail, which is what the rubric language in most classrooms describes anyway.

Where can I find a free NRNP 6557 Week 3 sample paper?

The ulcer versus stent case management paper is reproduced here with the collision, the ordering argument, the plan in sequence and the monitoring section.

Why does the ulcer come first in NRNP 6557 Week 3?

Because uncontrolled bleeding threatens life within hours, while a short, managed pause in one antiplatelet carries a smaller risk. The example continues aspirin and resumes ticagrelor early.